Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001193125-15-112108
Filing Date
2015-03-30
Accepted
2015-03-30 17:24:14
Documents
18
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 40-F d891272d40f.htm 40-F 36043
2 EX-99.1 d891272dex991.htm EX-99.1 305496
3 EX-99.2 d891272dex992.htm EX-99.2 570046
4 EX-99.3 d891272dex993.htm EX-99.3 194058
5 EX-99.4 d891272dex994.htm EX-99.4 9049
6 EX-99.5 d891272dex995.htm EX-99.5 9037
7 EX-99.6 d891272dex996.htm EX-99.6 3582
8 EX-99.7 d891272dex997.htm EX-99.7 3568
9 EX-99.8 d891272dex998.htm EX-99.8 2934
10 GRAPHIC g891272ex1.jpg GRAPHIC 119727
11 GRAPHIC g891272ex2.jpg GRAPHIC 124794
12 GRAPHIC g891272ex99_2cov.jpg GRAPHIC 56253
13 GRAPHIC g891272ex99_2pg05.jpg GRAPHIC 45662
14 GRAPHIC g891272ex99_2pg06.jpg GRAPHIC 45662
15 GRAPHIC g891272footer.jpg GRAPHIC 3629
16 GRAPHIC g891272logo.jpg GRAPHIC 2718
17 GRAPHIC g891272new.jpg GRAPHIC 4926
18 GRAPHIC g891272pwc.jpg GRAPHIC 4693
  Complete submission text file 0001193125-15-112108.txt   1698377
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-36421 | Film No.: 15735568
SIC: 2834 Pharmaceutical Preparations